Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 3, 2022
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
[ Wed, Aug 03rd 2022
] - WOPRAI
Tue, August 2, 2022
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
[ Tue, Aug 02nd 2022
] - WOPRAI
Andrew Mok Downgraded (AMED) to Strong Sell and Decreased Target to $95 on, Aug 2nd, 2022
Andrew Mok of UBS, Downgraded "Amedisys, Inc." (AMED) to Strong Sell and Decreased Target from $145 to $95 on, Aug 2nd, 2022.
Andrew has made no other calls on AMED in the last 4 months.
There are 10 other peers that have a rating on AMED. Out of the 10 peers that are also analyzing AMED, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tao Qiu of "Stifel" Initiated at Hold and Held Target at $128 on, Wednesday, June 29th, 2022
- Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $107 on, Tuesday, June 21st, 2022
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $125 on, Tuesday, June 21st, 2022
These are the ratings of the 7 analyists that currently disagree with Andrew
- John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $140 on, Monday, August 1st, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $154 on, Friday, July 29th, 2022
- Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $165 on, Thursday, July 28th, 2022
- David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $150 on, Thursday, July 14th, 2022
- Joanna Gajuk of "B of A Securities" Downgraded from Hold to Sell and Decreased Target to $102 on, Tuesday, June 21st, 2022
- Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $175 on, Tuesday, June 21st, 2022
- A.J. Rice of "Credit Suisse" Maintained at Buy with Increased Target to $182 on, Friday, April 29th, 2022
